Ayala Pharmaceuticals Inc (ADXS)

[equaloppforall]

Well, a few things.

I agree that it is atypical for companies to be offered an 800% premium over the current price in most instances, like it was for TBRA. Which is why I also provided the example of Celator (CPXX), which was run up from $1.50 to $15 in 3 months in preparation for a $30 buyout. Only a 100% premium.

CPXX wasn't offered a $3 buyout by Jazz when it was trading at $1.50. However, that is fbg's logic for ADXS. Unless we are selling tomorrow morning, ADXS' current $6.40 SP means absolutely nothing. And therefore fbg's $15 to $20 number has no basis.

Additionally, the current share price of ADXS has been arrived at in the last 1 month due to massive shorting on top of what already short numbers. It was also demonstrably manipulated in multiple instances using insider info and HFT. Recall the $22 to $14 take down in 1 minute on September 17, 2015 right after the best ever GOG phase 2 results were released? Yes, ADXS is also an ATYPICAL stock.

BPs will be aware of the true value of this company when the time for buyout arrives. And it sure as heel won't be anywhere near $20.